Skip to main content

Table 1 Baseline characteristics of participants by incident CHD

From: Coronary risk in relation to genetic variation in MEOX2 and TCF15 in a Flemish population

Characteristic Non-cases Cases All
1921 106 2027
N° with characteristics (%)    
 Women 1006 (52.4) 28 (26.4)‡ 1034 (51.0)
 Current smoker 566 (29.6) 39 (36.8) 605 (29.9)
 Drinking alcohol 565 (29.4) 21 (19.8)* 586 (28.9)
 Diabetes mellitus 26 (1.4) 7 (6.6)‡ 33 (1.6)
 Hypertension 432 (22.5) 54 (50.9)‡ 486 (24.0)
 Treated hypertension 189 (9.8) 25 (23.6)‡ 214 (10.6)
 History of CHD 30 (1.6) 11 (10.4)‡ 41 (2.0)
Mean of characteristic (±SD)    
 Age, years 42.8 ± 14.1 57.4 ± 11.3‡ 43.6 ± 14.3
 Body mass index, kg/m2 25.6 ± 4.3 27.1 ± 3.9‡ 25.7 ± 4.3
 Waist-to-hip ratio 0.84 ± 0.09 0.91 ± 0.08‡ 0.85 ± 0.09
 Systolic blood pressure, mm Hg 124.5 ± 15.2 135.3 ± 15.8‡ 125.0 ± 15.4
 Diastolic blood pressure, mm Hg 76.0 ± 9.4 78.6 ± 9.9† 76.2 ± 9.5
 Heart rate, beats per minute 69.2 ± 9.5 69.9 ± 9.0 69.3 ± 9.5
 Total cholesterol, mmol/L 5.46 ± 1.14 6.06 ± 1.15‡ 5.49 ± 1.15
 HDL cholesterol, mmol/L 1.40 ± 0.39 1.16 ± 0.33‡ 1.37 ± 0.39
 Total-to-HDL cholesterol ratio 4.21 ± 1.58 5.75 ± 2.30‡ 4.29 ± 1.66
 Serum creatinine, μmol/L 90.2 ± 16.8 104.3 ± 19.4‡ 91.1 ± 16.8
 Plasma glucose, mmol/L 5.03 ± 1.27 5.48 ± 2.29‡ 5.05 ± 1.35
  1. HDL cholesterol refers to the serum concentration of high-density lipoprotein cholesterol. Diabetes mellitus was a fasting or random plasma glucose level exceeding 7.0 or 11.1 mmol/L, or use of antidiabetic agents. Hypertension was a blood pressure of ≥140 mm Hg systolic or ≥90 mm Hg diastolic or use of antihypertensive drugs. Significance of the differences between non-cases and cases: * p ≤ 0.05; † p ≤ 0.01; ‡ p ≤ 0.001